-
Adocia S.A.S., Lyon, France Business: Musculoskeletal, Dermatology Date announced: 1/26/12 Type: IPO To be raised: Up to 29.1 million ($37.6 million) Shares: 1.4 million Price: 13-15.88 Underwriters: DSF; Invest …
Published on 1/30/2012
-
ChemoCentryx Inc., Mountain View, Calif. Business: Autoimmune, Cancer Date announced: 1/23/12 Type: IPO To be raised: Up to $73.6 million Shares: 4 million Price: $14-$16 Underwriters: JPMorgan; Citigroup; Cowen …
Published on 1/30/2012
-
Tvax Biomedical Inc., Lenexa, Kan. Business: Cancer, Infectious Date announced: 1/23/12 Type: IPO To be raised: Up to $25.3 million Shares: 2 million Price: $9-$11 Underwriters: Roth Capital Partners; Cantor Fitzgerald;…
Published on 1/30/2012
-
Axonia Medical Inc., Kalamazo, Mich. Business: Transplant Date completed: 12/13/11 Type: Venture financing Raised: $1 million Investor: Southwest Michigan First Life Science Fund Note: The company raised $1 million …
Published on 1/30/2012
-
CN Creative Ltd., Manchester, U.K. Business: Neurology Date completed: 1/25/12 Type: Venture financing Raised: 2 million ($3.1 million) Investor: Advent Life Sciences
Published on 1/30/2012
-
Eyevensys S.A.S., Paris, France Business: Ophthalmic Date completed: 1/23/12 Type: Venture financing Raised: 950,000 ($1.2 million) Investors: InnoBio Fund; Inserm Transfert Initiative
Published on 1/30/2012
-
GeneCentric Diagnostics Inc., Durham, N.C. Business: Diagnostic Date completed: 9/2/11 Type: Venture financing Raised: $250,000 Investor: Hatteras Venture Partners
Published on 1/30/2012
-
Generex Biotechnology Corp. (OTCBB:GNBT), Toronto, Ontario Business: Drug delivery Date completed: 1/25/12 Type: Debt financing Raised: C$3.6 million ($3.6 million) Investors: Private investors Note: The offering …
Published on 1/30/2012
-
Oragenics Inc. (OTCBB:ORNI), Alachua, Fla. Business: Dental, Infectious, Diagnostic Date completed: 1/25/12 Type: Debt financing Raised: $750,000 Investor: Koski Family Note: Oragenics drew down the remaining $750,000 …
Published on 1/30/2012
-
PolyPid Ltd., Ness Ziona, Israel Business: Drug delivery Date completed: 1/23/12 Type: Venture financing Raised: $2 million Investors: Xenia Venture Capital; private investors
Published on 1/30/2012
-
Prosensa B.V., Leiden, the Netherlands Business: Musculoskeletal Date completed: 1/25/12 Type: Venture financing Raised: 23 million ($29.7 million) Investors: New Enterprise Associates; Abingworth Management; LSP-Life …
Published on 1/30/2012
-
Stentys S.A. (Euronext:STNT), Paris, France Business: Cardiovascular Date completed: 1/26/12 Type: Private placement Raised: 8.3 million ($10.7 million) Shares: 574,639 Price: Not disclosed Shares after offering: 7.8 …
Published on 1/30/2012
-
Tonix Pharmaceuticals Holding Corp. (OTCBB:TNXP), New York, N.Y. Business: Musculoskeletal, Neurology Date completed: 1/23/12 Type: Private placement of units Raised: $2.4 million Units: 172 Price: $25,000 (unit) Shares…
Published on 1/30/2012
-
Trius Therapeutics Inc. (NASDAQ:TSRX), San Diego, Calif. Business: Infectious Date completed: 1/26/12 Type: Follow-on Raised: $45.2 million Shares: 8.6 million Price: $5.25 Shares after offering: 37.1 million …
Published on 1/30/2012
-
Verastem Inc. (NASDAQ: VSTM), Cambridge, Mass. Business: Cancer Date completed: 1/26/12 Type: IPO Raised: $55 million Shares: 5.5 million Price: $10 Shares after offering: 20.2 million Underwriters: UBS; Leerink; Lazard…
Published on 1/30/2012
-
Acusphere Inc. (Pink:ACUS), Lexington, Mass. Business: Diagnostic, Drug delivery Date announced: 1/20/12 Acusphere shareholders approved a 1-for-10 reverse stock split. Following the split, the company will have 5.1 …
Published on 1/30/2012
-
Aeterna Zentaris Inc. (TSX: AEZ; NASDAQ:AEZS), Quebec City, Quebec Business: Endocrine/Metabolic, Cancer Date announced: 1/23/12 Aeterna established an at-the-market program to sell up to 10.4 million of its common …
Published on 1/30/2012
-
Sequenom Inc. (NASDAQ: SQNM), San Diego, Calif. Business: Diagnostic, Genomics, Supply/Service Date announced: 1/25/12 Sequenom raised $8.1 million through the sale of 2 million shares at $4.15 to cover the …
Published on 1/30/2012
-
EntreMed Inc. (NASDAQ: ENMD), Rockville, Md. Business: Cancer, Autoimmune Date announced: 1/23/12 Type: Private placement of convertible notes and warrants To be raised: $10 million Shares outstanding prior: 12.2 …
Published on 1/30/2012
-
OncoSec Medical Inc. (OTCBB: ONCS), San Diego, Calif. Business: Cancer Date announced: 1/24/12 Type: Private placement of units To be raised: Up to $10 million Units: TBD Price prior: $0.40 Placement agent: Rodman …
Published on 1/30/2012
-
Cempra Holdings LLC, Chapel Hill, N.C. Business: Infectious Date announced: 1/17/12 Type: IPO To be raised: Up to $89.7 million Shares: 6 million Price: $11-$13 Underwriters: Stifel Nicolaus Weisel; Leerink; Cowen; …
Published on 1/23/2012
-
Verastem Inc., Cambridge, Mass. Business: Cancer Date announced: 1/13/12 Type: IPO To be raised: Up to $57 million Shares: 4.5 million Price: $9-$11 Underwriters: UBS; Leerink; Lazard; Oppenheimer; Rodman Overallotment:…
Published on 1/23/2012
-
Arrogene Nanotechnology Inc., Los Angeles, Calif. Business: Cancer, Drug delivery, Diagnostic Date completed: 1/18/12 Type: Venture financing Raised: $500,000 Placement agent: WestPark Capital
Published on 1/23/2012
-
Cambridge Heart Inc. (OTCBB:CAMH), Tewksbury, Mass. Business: Diagnostic Date completed: 1/18/12 Type: Private placement of senior convertible notes Raised: $2.5 million Shares outstanding prior: 99.7 million Investors:…
Published on 1/23/2012
-
Carticept Medical Inc., Alpharetta, Ga. Business: Musculoskeletal, Drug delivery Date completed: 1/18/12 Type: Venture financing Raised: $10 million Investors: Domain Associates; New Enterprise Associates; SonoSite Inc.
Published on 1/23/2012